A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair)

References

• Asher MI, Montefort S, Björksten B, et al. ISAAC phase three study group. Lancet 2006;368:733-43
   PubMed Web of Science ®Google Scholar
• Ait-Khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-oldd children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007;62:247-58
   PubMed Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling HJ. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53:1-42
   Web of Science ®Google Scholar
• Bacharier LB, Boner A, Carlsen KH, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:5-34
   PubMed Web of Science ®Google Scholar
• Roberts G, Hurley C, Turcanu V, et al. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 2006;117:263-8
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Guerra L, Pasquali M, et al. Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol 2004;93:3-12
   PubMed Web of Science ®Google Scholar
• Bahçeciler NN, Cobanoglu N. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma. Immunotherapy 2011;3(6):747-56
   PubMed Web of Science ®Google Scholar
• Welsh PW, Zimmermann EM, Yunginger JW, et al. Preseasonal intranasal immunotherapy with nebulized short ragweed extract. J Allergy Clin Immunol 1981;67:237-42
   PubMed Web of Science ®Google Scholar
• Georgitis JW, Reisman RE, Clayton WF, et al. Local nasal immunotherapy for grass allergic rhinitis. J Allergy Clin Immunol 1983;71:71-6
   PubMed Web of Science ®Google Scholar
• Andri L, Senna GE, Betteli C, et al. Local nasal immunotherapy for dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol 1993;91:587-96
   Web of Science ®Google Scholar
• D’Amato G, Lobelafo G, Liccardi Gi, et al. A double blind placebo controlled trial of local nasal immunotherapy in allergic rhinitis to parietaria pollen. Clin Exp Allegy 1995;25:141-8
   PubMed Web of Science ®Google Scholar
• Marcucci F, Sensi LG, Caffarelli C, et al. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides. Allergy 2002;57:3-28
   Web of Science ®Google Scholar
• Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12
   PubMed Web of Science ®Google Scholar
• Bahceciler NN, Isik U, Barlan IB, et al. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001;32:49-55
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Yazi D, Gocmen I, et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol 2007;18:508-15
   PubMed Web of Science ®Google Scholar
• Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851-7
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33:206-10
   PubMed Web of Science ®Google Scholar
• Bahceciler NN, Galip N. Comparing subcutaneous and sublingual ımmunotherapy: what do we know? Curr Opin Allergy Clin Immunol 2012;12(6):640-7
   PubMed Web of Science ®Google Scholar
• Keles S, Karakoc-Aydiner E, Ozen A, et al. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes. J Allergy Clin Immunol 2011;128(4):808-15
   PubMed Web of Science ®Google Scholar
• Mungan D, Misirligil Z, Gürbüz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma-a placebo controlled study. Ann Allergy Asthma Immunol 1999;82(5):485-90
   PubMed Web of Science ®Google Scholar
• Durham SR, Yang WH, Pederson MR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117:802-9
   PubMed Web of Science ®Google Scholar
• Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. Allergy Clin Immunol 2007;120:1338-45
   Google Scholar
• Dahl R, Stender A, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006;61:185-90
   PubMed Web of Science ®Google Scholar
• Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5 grass pollen sublingual immunotherapy in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009;123:160-6
   PubMed Web of Science ®Google Scholar
• Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009;64:179-86
   PubMed Web of Science ®Google Scholar
• Bufe A, Eberle P, Franke-Beckmann E, et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol 2009;123:167-73
   PubMed Web of Science ®Google Scholar
• Maloney J, Bernstein DI, Nelson H, et al. Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial. Ann Allergy Asthma Immunol 2014;112(2):146-53
   PubMed Web of Science ®Google Scholar
• Pastorello EA, Losappio L, Milani S, et al. 5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study. J Asthma Allergy 2013;6:127-33
   PubMedGoogle Scholar
• Suárez-Fueyo A, Ramos T, Galán A, et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol 2014;133(1):130-8
   PubMed Web of Science ®Google Scholar
• Creticos PS, Maloney J, Bernstein DI, et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol 2013;131(5):1342-9
   PubMed Web of Science ®Google Scholar
• Cox LS, Casale TB, Nayak AS, et al. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE. J Allergy Clin Immunol 2012;130(6):1327-34
   PubMed Web of Science ®Google Scholar
• Kulig M, Bergmann R, Klettke U, et al. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999;103(6):1173-9
   PubMed Web of Science ®Google Scholar
• Chapman MD, Pomés A, Breiteneder H, et al. Nomenclature and structural biology of allergens. Allergy Clin Immunol 2007;119(2):414-20
   Google Scholar
• Pomés A. Allergen structures and biologic functions: the cutting edge of allergy research. Curr Allergy Asthma Rep 2008;8(5):425-32
   PubMed Web of Science ®Google Scholar
• van Bronswijk JE, Sinha RN. Pyroglyphid mites (Acari) and house dust allergy. J Allergy 1971;47(1):31-52
   PubMedGoogle Scholar
• Phipps S, Lam CE, Kaiko GE, et al. Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses. Am J Respir Crit Care Med 2009;179(10):883-93
   PubMed Web of Science ®Google Scholar
• Gavino AC, Needham GR, High WA. Atopic dermatitis, patch testing, and house dust mites: a brief review. Dermatitis 2008;19(3):121-8
   PubMed Web of Science ®Google Scholar
• Kemp AS. Allergic rhinitis. Paediatr Respir Rev 2009;10(2):63-8
   PubMed Web of Science ®Google Scholar
• Høst A, Halken S. The role of allergy in childhood asthma. Allergy 2000;55(7):600-8
   PubMed Web of Science ®Google Scholar
• Platts-Mills T, de Weck AL, Aalberse R, et al. J Allergy Clin Immunol 1989;83(2 Pt 1):416-27
   PubMed Web of Science ®Google Scholar
• Sasai K, Furukawa S, Muto T, et al. Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease. J Pediatr 1996;128(6):834-40
   PubMed Web of Science ®Google Scholar
• Apelberg BJ, Aoki Y, Jaakkola JJ. Systematic review: exposure to pets and risk of asthma and asthma-like symptoms. J Allergy Clin Immunol 2001;107(3):455-60
   PubMed Web of Science ®Google Scholar
• Roost HP, Künzli N, Schindler C, et al. Role of current and childhood exposure to cat and atopic sensitization. European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104(5):941-7
   PubMed Web of Science ®Google Scholar
• Custovic A, Taggart SC, Francis HC, et al. Exposure to house dust mite allergens and the clinical activity of asthma. J Allergy Clin Immunol 1996;98(1):64-72
   PubMed Web of Science ®Google Scholar
• Lau S, Illi S, Sommerfeld C, et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 2000;356(9239):1392-7
   PubMed Web of Science ®Google Scholar
• Illi S, von Mutius E, Lau S, et al. The pattern of atopic sensitization is associated with the development of asthma in childhood. J Allergy Clin Immunol 2001;108(5):709-14
   PubMed Web of Science ®Google Scholar
• Kuehr J, Frischer T, Meinert R. Sensitization to mite allergens is a risk factor for early and late onset of asthma and for persistence of asthmatic signs in children. J Allergy Clin Immunol 1995;95(3):655-62
   PubMed Web of Science ®Google Scholar
• Compalati E, Passalacqua G, Bonini M, et al. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009;64(11):1570-9
   PubMed Web of Science ®Google Scholar
• Radulovic S, Calderon MA, Wilson D, et al. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2010(12): CD002893
   PubMed Web of Science ®Google Scholar
• Lin SY, Erekosima N, Kim JM, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013;309(12):1278-88
   PubMed Web of Science ®Google Scholar
• Eifan AO, Calderon MA, Durham SR. Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma. Expert Opin Biol Ther 2013;13(11):1543-56
   PubMed Web of Science ®Google Scholar
• Pham-Thi N, Scheinmann P, Fadel R, et al. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007;18:47-57
   PubMed Web of Science ®Google Scholar
• O’Hehir RE, Gardner LM, de Leon MP, et al. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells. Am J Respir Crit Care Med 2009;180:936-47
   PubMed Web of Science ®Google Scholar
• Bousquet J, Scheinmann P, Guinnepain MT, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54(3):249-60
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Pasquali M, Ariano R, et al. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 2006;61(7):849-54
   PubMed Web of Science ®Google Scholar
• de Bot CM, Moed H, Berger MY, et al. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care. Pediatr Allergy Immunol 2012;23(2):150-8
   PubMed Web of Science ®Google Scholar
• Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990;18(5):277-84
   PubMed Web of Science ®Google Scholar
• Bush RK, Swenson C, Fahlberg B, et al. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol 2011;127(4):974-81.e1.7
   PubMed Web of Science ®Google Scholar
• Aydogan M, Eifan AO, Keles S, et al. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Respir Med 2013;107(9):1322-9
   PubMed Web of Science ®Google Scholar
• Hirsch T, Sähn M, Leupold W. Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997;8(1):21-7
   PubMed Web of Science ®Google Scholar
• Niu CK, Chen WY, Huang JL, et al. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. Respir Med 2006;100:1374-83
   PubMed Web of Science ®Google Scholar
• Lue KH, Lin YH, Sun HL, et al. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 2006;17:408-15
   PubMed Web of Science ®Google Scholar
• Ippoliti F, De Santis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003;14(3):216-21
   PubMed Web of Science ®Google Scholar
• Tonnel AB, Scherpereel A, Douay B, et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004;59(5):491-7
   PubMed Web of Science ®Google Scholar
• Guez S, Vatrinet C, Fadel R, et al. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55(4):369-75
   PubMed Web of Science ®Google Scholar
• Queirós MG, Silva DA, Siman IL, et al. Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children. Pediatr Allergy Immunol 2013;24(8):752-61
   PubMed Web of Science ®Google Scholar
• Wang DH, Chen L, Cheng L, et al. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. Laryngoscope 2013;123(6):1334-40
   PubMed Web of Science ®Google Scholar
• Pajno GB, Morabito L, Barberio G, et al. Clinical and immunological effects of long term sublingual immunotherapy in asthmatic children sensitized to mite: a double blind study. Allergy 2000;55:842-9
   PubMed Web of Science ®Google Scholar
• Keleş S, Karakoç-Aydıner E, Tevetoğlu A, et al. A novel approach in sublingual allergen specific immunotherapy; combination with subcutaneous immunotherapy. J Allergy Clin Immunol 2009;128(4):808-15
   Web of Science ®Google Scholar
• Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351(9103):629-32
   PubMed Web of Science ®Google Scholar
• Stallergenes. Available from: www.stallergenes.com/en/our-products/sublingual-allergen-immunotherapyhtml
   Google Scholar
• ALK allergy vaccines. Available from: www.alk-abello.com/products/allergyvaccines/Pages/ContVariant.aspx
   Google Scholar
• Eslami A, Gallant-Behm CL, Hart DA, et al. Expression of integrin alphavbeta6 and tgf-beta in scarless vs scar-forming wound healing. J Histochem Cytochem 2009;57:543-57
   PubMed Web of Science ®Google Scholar
• Marcucci F, Incorvaia C, Sensi L, et al. Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int J Immunolpathol Pharmacol 2008;21:609-14
   PubMed Web of Science ®Google Scholar
• Bagnasco M, Altrinetti V, Pesce G, et al. Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol 2005;138:197-202
   PubMed Web of Science ®Google Scholar
• Bagnasco M, Passalacqua G, Villa G, et al. Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers. Clin Exp Allergy 2001;31:54-60
   PubMed Web of Science ®Google Scholar
• Moingeon P. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract 2013;1(3):228-41
   PubMed Web of Science ®Google Scholar
• Bohle B, Kinaciyan T, Gerstmayr M, et al. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 2007;120:707-13
   PubMed Web of Science ®Google Scholar
• Allam JP, Niederhagen B, Bucheler M, et al. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 2006;61:166-72
   PubMed Web of Science ®Google Scholar
• Allam JP, Stojanovski G, Friedrichs N, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens şn sublingual immunotherapy? Allergy 2008;63:720-7
   PubMed Web of Science ®Google Scholar
• Allam JP, Novak N, Fuchs C, et al. Characterization of dendritic cells from human oral mucosa: a new Langerhans’ cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol 2003;112:141-8
   PubMed Web of Science ®Google Scholar
• Allam JP, Klein E, Bieber T, et al. Transforming growth factor-beta 1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1 a dendritic cells in vitro. J Invest Dermatol 2004;123:676-82
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Bagnasco M, Mariani G, et al. Local immunotherapy: pharmacokinetics and efficacy. Allergy 1998;53:477-84
   PubMed Web of Science ®Google Scholar
• Allam JP, Peng WM, Appel T, et al. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 2008;121:368-74
   PubMed Web of Science ®Google Scholar
• Strobel S, Mowat AM. Immune responses to dietary antigens: oral tolerance. Immunol Today 1998;19:173-81
   PubMedGoogle Scholar
• Flicker S, Steinberg P, Norderhaug L, et al. Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur J Immunol 2002;32:2156-62
   PubMed Web of Science ®Google Scholar
• Bahceciler NN, Arikan C, Taylor A, et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites. Int Arch Allergy Immunol 2005;136(3):287-94
   PubMed Web of Science ®Google Scholar
• Scadding GW, Shamji MH, Jacobson MR, et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 2010;40:598-606
   PubMed Web of Science ®Google Scholar
• Swamy RS, Reshamwala N, Hunter T, et al. Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin Immunol 2012;130:215-24
   PubMed Web of Science ®Google Scholar
• Zimmer A, Bouley J, Le Mignon M, et al. A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy. J Allergy Clin Immunol 2012;129:1020-30
   PubMed Web of Science ®Google Scholar
• Mosbech H. Tolerability and efficacy of house dust mite AIT. Allergy 2011;66(Suppl 95):55-6
   PubMed Web of Science ®Google Scholar
• Zeldin RK, Betting P, Le Gall M, et al. Safety of sublingual tablets of House Dust Mite allergen extracts in adults with House Dust Mite- associated allergic asthma. American Thoracic Society Congress 2013. Pennsylvannia; poster #208:88
   Google Scholar
• Corzo JL, Carrillo T, Pedemonte C, et al. Tolerability during double-blind randomized phase I trials with the house dust mite allergy immunotherapy tablet in adults and children. J Investig Allergol Clin Immunol 2014;24(3):154-61
   PubMed Web of Science ®Google Scholar
• Roux M. Efficacy of house dust mite sublingual immunotherapy in adults with allergic rhinitis: results of an environmental exposure chamber study. J Allergy Clin Immunol 2013;2: AB37(90)
   Google Scholar
• Mosbech H, Deckelmann R, de Blay F, et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2014;2: pii:S0091-6749(14)00440-0
   Google Scholar
• ALKAbello. 2014,June9 https://globenewswire.com/news-release/2014/06/09/642629/0/en/ALK-presents-Phase-III-data-on-house-dust-mite-SLIT-tablet-at-EAACI-Annual-Congress-in-Copenhagen.html
   Google Scholar
• Bergmann KC, Demoly P, Worm M, et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. J Allergy Clin Immunol 2014;133(6):1608-14
   PubMed Web of Science ®Google Scholar
• Rowe-Jones JM. The link between the nose and lung, perennial rhinitis and asthma-is it the same disease? Allergy 1997;52(36 Suppl):20-8
   PubMedGoogle Scholar
• Rachelefsky GS. National guidelines needed to manage rhinitis and prevent complications. Ann Allergy Asthma Immunol 1999;82(3):296-305
   PubMed Web of Science ®Google Scholar
• Linneberg A, Henrik Nielsen N, Frølund L, et al. Copenhagen Allergy Study. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002;57(11):1048-52
   PubMed Web of Science ®Google Scholar